On September 22, in New York City, the Medulloblastoma Initiative joined the Clinton Global Initiative 2026, one of the world’s most influential platforms for global action.
Fernando Goldsztein, Founder and CEO of MBI, was invited to participate as a panelist in the Health Working Session, sharing MBI’s perspective on how collaboration, urgency, and innovation can help accelerate medical research.
The event brought together leaders from different fields to discuss solutions to some of the world’s most urgent challenges. For MBI, it was a meaningful opportunity to bring pediatric brain cancer to a global stage and expand the conversation around the need for faster progress.
The participation reflects MBI’s commitment to bringing together people, resources, and ideas to accelerate research and advance the search for a cure for medulloblastoma.
